EKSO BIONICS HOLDINGS, INC.
For the period ended Mar 31, 2026. Filed Apr 28, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed Apr 28, 2026
CHRN$11.62+8.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Exhibit Number | Description | |
| 3.1 | Restated Articles of Incorporation of the Registrant (incorporated by reference from Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on April 26, 2023) | |
| 3.2 | Amended and Restated By-Laws of the Registrant (incorporated by reference from Exhibit 3.2 to the Company’s Current Report on Form 8-K filed on April 26, 2023) | |
| 3.3 | Certificate of Designation of the Powers, Preferences and Relative, Participating, Optional and Other Restrictions of Series B Convertible Preferred Stock (incorporated by reference from Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on January 22, 2026) | |
| 3.4 | Amendment No. 1 to the Amended and Restated Bylaws of Ekso Bionics Holdings, Inc. (incorporated by reference from Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on February 23, 2026) | |
| 4.1 | Form of Common Stock Purchase Warrant (incorporated by reference from Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on January 22, 2026) | |
| 10.1 | Form of Registration Rights Agreement (incorporated by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on January 22, 2026) | |
| 10.2# | Form of Securities Purchase Agreement (incorporated by reference from Exhibit 99.1 to the Company’s Current Report on Form 8-K filed on January 22, 2026) | |
| 10.3#* | Contribution and Exchange Agreement, dated February 15, 2026, by and among Ekso Bionics Holdings, Inc., APLD ChronoScale HoldCo LLC, APLD Intermediate HoldCo LLC, and Applied Digital Cloud Corporation (incorporated by reference from Exhibit 10.30 to the Company’s Annual Report on Form 10-K filed on February 23, 2026) | |
| 31.1* | Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
| 31.2* | Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
| 32.1+ | Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
| 32.2+ | Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
| 101* | The following financial statements from the Ekso Bionics Holdings, Inc. Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, formatted in Inline Extensible Business Reporting Language (“iXBRL”): | |
| • | unaudited condensed consolidated balance sheets; | |
| • | unaudited condensed consolidated statements of operations and comprehensive income (loss); | |
| • | unaudited condensed consolidated statements of stockholders’ equity; | |
| • | unaudited condensed consolidated statement of cash flows; and | |
| • | notes to unaudited condensed consolidated financial statements. | |
| 101.ins | Inline XBRL Instant Document | |
| 101.sch | Inline XBRL Taxonomy Schema Document | |
| 101.cal | Inline XBRL Taxonomy Calculation Linkbase Document | |
| 101.def | Inline XBRL Taxonomy Definition Linkbase Document | |
| 101.lab | Inline XBRL Taxonomy Label Linkbase Document | |
| 101.pre | Inline XBRL Taxonomy Presentation Linkbase Document | |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
| # | Certain of the exhibits and schedules in this exhibit have been omitted in accordance with Regulation S-K Item 601. The Company agrees to furnish supplementally a copy of all omitted exhibits and schedules to the Securities and Exchange Commission upon its request. |
| * | Filed herewith. |
| + | Furnished herewith. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.